Form 990 for tax year 2024

Totals

Total revenue

$18,903,896

Total expenses

$17,912,585

Contributions and grants received

$18,237,103

Grants paid

$5,676,081

Program service revenue

$0

Investment income

$865,489

Other revenue

-$198,696

Total assets, end of year

$17,538,090

Total liabilities, end of year

$10,004,026

Net assets or fund balances, end of year

$7,534,064

Program services expenses (Part IX)

$12,948,490

Management and general expenses

$1,500,208

Fundraising expenses

$3,463,887

Program service expenses (Part III)

$12,948,490

Program services were 72.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• RESEARCH AND GRANTING PROGRAMS:IN 2024, CCRF AWARDED NEARLY $6 MILLION AS RESEARCH AND PROGRAM GRANTS IN THE FOLLOWING AREAS OF FOCUS: - HARD-TO-TREAT CANCERS: CCRF PRIORITIZES RESEARCH FOR CANCERS WITH PERSISTENTLY LOW SURVIVAL RATES. THESE INCLUDE HIGHLY AGGRESSIVE AND OFTEN FATAL CANCERS SUCH AS BRAIN TUMORS, SARCOMAS, AND CERTAIN TYPES OF LEUKEMIAS. IN 2024, WE AWARDED $1,000,000 TO SUPPORT A CLINICAL TRIAL ON RELAPSED WILMS TUMOR LED BY A RESEARCHER AT MEMORIAL SLOAN KETTERING. WE ALSO AWARDED A TOTAL OF $500,000 TO TWO ADDITIONAL RESEARCHERS AT MEMORIAL SLOAN KETTERING TO SUPPORT CLINICAL TRIALS ON A PARTICULARLY HARD-TO-TREAT TYPE OF ACUTE MYELOID LEUKEMIA (AML) AND PEDIATRIC SOLID TUMORS. IN ADDITION, CCRF AWARDED MORE THAN $1,000,000 TO RESEARCHERS AT MULTIPLE RESEARCH INSTITUTIONS FOR WORK ON CANCERS INCLUDING RHABDOMYOSARCOMA, OSTEOSARCOMA, BRAIN TUMORS AND HEPATOBLASTOMA. FINALLY, CCRF MADE A GRANT OF $2,000,000 TO ESTABLISH AN ENDOWED CHAIR IN PEDIATRIC BRAIN TUMOR RESEARCH AT THE UNIVERSITY OF MINNESOTA. - SURVIVORSHIP: MANY CHILDHOOD CANCER SURVIVORS LIVE WITH ENDURING CONSEQUENCES OF CHEMOTHERAPY, RADIATION, OR SURGICAL INTERVENTIONS, INCLUDING COGNITIVE IMPAIRMENT, CARDIAC ISSUES AND INFERTILITY. CCRF SUPPORTS RESEARCHERS DOING WORK ON NEW TREATMENT MODALITIES THAT WILL REDUCE ADVERSE LONG-TERM EFFECTS, INTERVENTIONS TO PROMOTE HEALTH AMONG SURVIVORS, AND OTHER STRATEGIES TO MITIGATE ADVERSE LONG-TERM EFFECTS. IN 2024, CCRF GRANTED A TOTAL OF $600,000 TO RESEARCHERS AT CHILDREN'S NATIONAL, THE UNIVERSITY OF MICHIGAN AND THE UNIVERSITY OF MINNESOTA FOR STUDIES FOCUSED ON HEALTHY SURVIVORSHIP.- HEALTH DISPARITIES: DISPARITIES IN PEDIATRIC CANCER OUTCOMES ARE INFLUENCED BY FACTORS INCLUDING RACE, ETHNICITY AND SOCIOECONOMIC BACKGROUND. CCRF SUPPORTS RESEARCH ON DISPARITIES IN CANCER OUTCOMES, WITH PARTICULAR ATTENTION PAID TO INTERVENTIONS AIMED AT PREVENTING OR MITIGATING THEM. IN 2024, CCRF AWARDED $250,000 TO RESEARCH LOOKING AT THE IMPACT OF FAMILY INCOME ON OUTCOMES FOR CHILDREN WITH LEUKEMIA.

  Expenses $6,321,697 · Grants $5,676,081

• EDUCATION AND AWARENESS PROGRAM:IN ADDITION TO FUNDING RESEARCH AND OFFERING SUPPORT PROGRAMS, WE GENERATE AWARENESS ABOUT THE NEED FOR CHILDHOOD CANCER RESEARCH AND PROVIDE EDUCATIONAL RESOURCES FOR RESEARCHERS. WE REACH MILLIONS OF PEOPLE THROUGH OUR WEBSITE, DIGITAL AND SOCIAL MEDIA PLATFORMS, AND IN-KIND TELEVISION AND PRINT ADVERTISING TO SHARE THE STORIES OF KIDS, FAMILIES, AND RESEARCHERS. WE'RE ALSO PROUD TO SUPPORT THE CANCER SURVIVORSHIP CONFERENCE, THE MARK E. NESBIT LECTURESHIP IN PEDIATRIC ONCOLOGY, AND THE NORMA K.C. RAMSAY, MD, DISTINGUISHED VISITING PROFESSOR LECTURESHIP SERIES. THESE BRING NATIONALLY RECOGNIZED CHILDHOOD CANCER EXPERTS TO MINNESOTA TO SPEAK ON CURRENT SURVIVORSHIP, CLINICAL AND RESEARCH ISSUES, AS WELL AS BUILD NEW RESEARCH COLLABORATIONS.

  Expenses $5,969,559

• FAMILY SUPPORT PROGRAMS:OUR DEDICATED FAMILY PROGRAMS IMPROVE THE WELL-BEING OF KIDS AND FAMILIES AS THEY NAVIGATE THE DIFFICULT EXPERIENCES OF CANCER TREATMENT, SURVIVORSHIP, OR BEREAVEMENT. THESE OFFERINGS INCLUDE: - THE BIG DREAMS TOUR - A CREATIVE OUTLET THAT REDUCES ISOLATION BY LEVERAGING AR, VR, AND XR TECHNOLOGY TO PROVIDE PEDIATRIC CANCER PATIENTS AN OPPORTUNITY TO GAME TOGETHER MONTHLY AND CREATE THEIR OWN ANIMATED MUSIC VIDEO, VIDEO GAME, OR VFX VIDEO; INCLUDING COMMUNITY EVENTS WHERE THEIR CREATIONS ARE BROUGHT TO LIFE IN VIRGINIA, MICHIGAN, MAINE AND MINNESOTA. - CAMP NORDEN - IN-PERSON AND VIRTUAL FIVE-DAY SUMMER CAMPS ARE DESIGNED ESPECIALLY TO MEET THE UNIQUE NEEDS OF CHILDREN WHO HAVE BEEN DIAGNOSED WITH CANCER AND SUPPORT FRIENDSHIP-BUILDING, SOLIDARITY WITH PEERS, INCREASED SELF-ESTEEM, AND A FEELING OF INDEPENDENCE. THESE CAMPS FOSTER COMMUNITY AND ELIMINATE FINANCIAL OR GEOGRAPHICAL BARRIERS TO ATTEND.-CC BEAR- OUR CURE CANCER "C.C." BEAR IS READY TO COMFORT AND CARE FOR THOSE WHO NEED HIM MOST AT NO COST TO FAMILIES. 619 BEARS WERE SENT TO CHILDREN WITH CANCER, AND THEIR SIBLINGS.

  Expenses $657,234

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• FRED HUTCHINSON CANCER CENTER

  $750,095

  DR. SOHEIL MESHINCHI FOR A CLINICAL TRIAL FOCUSED ON RARE AML

• CHILDREN'S HOSPITAL OF PHILADELPHIA

  $650,000

  DR. JOHN MARIS FOR PEDIATRIC NEUROBLASTOMA RESEARCH

• UNIVERSITY OF MINNESOTA FOUNDATION

  $650,000

  CAPITAL FUND

• UNIVERSITY OF MINNESOTA FOUNDATION

  $300,000

  CADE FAMILY ENDOWED CHAIR

• UNIVERSITY OF MINNESOTA FOUNDATION

  $214,901

  DR. BEAU WEBBER FOR OSTEOSARCOMA RESEARCH

• UNIVERSITY OF MINNESOTA FOUNDATION

  $200,000

  RESEARCH ON PEDIATRIC BRAIN AND NEURAL TUMORS

• UNIVERSITY OF MINNESOTA FOUNDATION

  $200,000

  CORRIGAN CGI EQUIPMENT

• LAD IN A BATTLE LLC

  $175,000

  FOR BIG DREAMS TOUR

• THE REGENTS OF THE UNIVERSITY OF MICHIGAN

  $150,000

  DR. ANAO ZHANG FOR RESEARCH ON PEDIATRIC CANCER SURVIVORS

• UNIVERSITY OF MINNESOTA FOUNDATION

  $150,000

  FOR PEDIATRIC CANCER RESEARCH

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type

form_990

Tax year

2024

Filed

20 October 2025

IRS schema version

2024v5.2

Source object

202522939349301507

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.